These results suggest that both transcriptional and post-transcriptional mechanisms regulate the expression of the NAPRT gene in cancer types, including mutations in transcription factor binding sites of CREB and Sp1, to promoter methylation and alternative splicing (88). Here, NAPRT is linked to cancer.